RECURSION PHARMACEUTICALS IN shareholders Q3 2023

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 190 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.9%.

RECURSION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
NVWM, LLC 123$9410.00%
CWM, LLC 6,184$470.00%
Allspring Global Investments Holdings, LLC 10,123$77,4400.00%
Financial Gravity Asset Management, Inc. 1$70.00%
Global Retirement Partners, LLC 300$2,1480.00%
Cresset Asset Management, LLC 15,077$115,3390.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 74,727$571,6620.00%
GROUP ONE TRADING, L.P. 6,229$47,6520.00%
PNC FINANCIAL SERVICES GROUP, INC. 1,969$15,0630.00%
Ancora Advisors LLC 23$1760.00%
BANK OF AMERICA CORP /DE/ 600$4,5900.00%
Parallel Advisors, LLC 65$4970.00%
OSAIC HOLDINGS, INC. 7,092$54,2490.00%
JANUS HENDERSON GROUP PLC 62,506$478,4800.00%
IFP Advisors, Inc 1$80.00%
TUCKER ASSET MANAGEMENT LLC 91$6960.00%
NewEdge Advisors, LLC 1,636$12,5150.00%
PRICE T ROWE ASSOCIATES INC /MD/ 52,975$4060.00%
NISA INVESTMENT ADVISORS, LLC 4,020$30,7530.00%
External links

This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q3 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.